This week’s episode, Brazil’s place in the race for a Covid-19 vaccine, was supported by AMEC, the Brazilian Association of Investors in Capital Markets. AMEC brings together around 60 institutional investors from Brazil and abroad — which have a combined portfolio of over USD 130 billion. AMEC works to support minority shareholders’ rights by fostering governance and stewardship principles that strengthen the market as a whole.
Brazil has miserably failed in its half-hearted attempt to contain the coronavirus. In five months, the country recorded almost 3 million infections and nearly 100 thousand deaths. And the spread of the disease shows no signs of slowing down. Ironically, however, the fact that the coronavirus spread is still active in Brazil means that it could well become the first country in the world to receive a Covid-19 vaccine.
Listen and subscribe to our podcast from your mobile device:
On this episode:
- Fernando Spilki is the president of the Brazilian Society for Virology. He coordinates a Brazilian effort to map the genome of the Sars-CoV-2 virus, which causes Covid-19. Dr. Spilki is also a member of the Advisory Board at the U.S.-based organization Dimensions Sciences, which fosters scientific research in Brazil.
Background reading on the Covid-19 vaccine:
- Don’t miss our Covid-19 Live Blog.
- Out July 21 Daily Briefing explained in detail at which stage is each vaccine being tested in Brazil.
- How Brazil’s economy can bounce back after the pandemic, according to reporter Rafael Lima.
- Besides the pandemic, Brazilian governors face multiple crises, José Roberto Castro explains.
- Brazilians return to work, but how many stayed away in the first place?
- Coronavirus aid sees Brazil’s poverty rates drop to its lowest level since 2004, writes reporter Laís Martins.
Do you have a suggestion for our next Explaining Brazil podcast? Drop us a line at [email protected]Support this podcast →